$SGEN Company News December pullback triggers fi
Post# of 102173
Posted On: 12/07/2013 12:47:34 PM
$SGEN Company News
December pullback triggers first technical test 11:33 a.m. Dec. 5, 2013 - Michael Ashbaugh
Six stocks to watch for some upside 2:21 p.m. April 11, 2013 - The Trading Deck
S&P 500 takes flight, reaches record territory 9:55 a.m. April 11, 2013 - Michael Ashbaugh
Five bullish charts to watch 3:15 p.m. March 7, 2013 - The Trading Deck
Thursday’s biggest movers; Apple at 5-month low 5:27 p.m. Nov. 8, 2012 - Sue Chang
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
2012 biotech medal winners ... so far 11:01 p.m. July 31, 2012 - Gil Morales
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three technical tests converge 9:40 a.m. July 18, 2012 - Michael Ashbaugh
MoKa's Morales sees Facebook, LinkedIn on cutting edge 11:34 a.m. June 25, 2012 - blogs.marketwatch.com
Tuesday’s biggest gaining and declining stocks 5:47 p.m. Feb. 14, 2012 - Sue Chang
Rackspace Hosting, Yingli rise after hours 5:44 p.m. Feb. 13, 2012 - Myra P. Saefong
Seattle Genetics falls on growth concerns 1:42 p.m. Nov. 4, 2011 - MarketWatch.com
ECB rattles the technical backdrop 9:45 a.m. Nov. 3, 2011 - Michael Ashbaugh
U.S. markets break from the “crash” range 11:19 a.m. Oct. 24, 2011 - Michael Ashbaugh
S&P 500 rattles the cage on a trend shift 9:35 a.m. Oct. 10, 2011 - Michael Ashbaugh
3 biotech stocks battle the ‘Dendreon Effect’ 6:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 2:49 p.m. July 15, 2011 - Kate Gibson
Seattle Genetics slides 11% on drug launch worries 9:06 a.m. July 15, 2011 - Val Brickates Kennedy
SEC sues Seattle Genetics employee over trades 12:43 p.m. Jan. 21, 2011 - Steve Goldstein
Seattle Genetics presents results from study of ADC candidate in B-cell malignancies 59 min ago - Seeking Alpha
Seattle Genetics Presents Interim Phase 1 from Novel Antibody-Drug Conjugate SGN-CD19A at ASH 2013 10:03 a.m. Today - benzinga.com
Insider Trading Alert - CTL, CNQR, EXPR, DLTR And SGEN Traded By Insiders 10:31 a.m. Dec. 6, 2013 - TheStreet.com
Top Insider Trades: SGEN RST ACCL DLTR 10:02 a.m. Dec. 6, 2013 - TheStreet.com
Seattle Genetics Inc. (SGEN): Today's Featured Drugs Winner 5:02 p.m. Dec. 3, 2013 - TheStreet.com
Bayer Eyeing Norwegian Oncology Firm - Analyst Blog 5:00 p.m. Nov. 27, 2013 - Zacks.com
A Hedge Fund is Buying Shares in These 2 Biotech Stocks 2:20 p.m. Nov. 27, 2013 - Wall St. Cheat Sheet
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
Cramer's Mad Money - 11 Things To Watch In The Week Ahead (11/22/13) 6:24 a.m. Nov. 24, 2013 - Seeking Alpha
Seattle Genetics' CEO Presents at Jefferies 2013 Global Healthcare Conference (Transcript) 9:06 a.m. Nov. 20, 2013 - Seeking Alpha
Seattle Genetics Larger Than S&P 500 Component E*trade Financial 4:41 p.m. Nov. 19, 2013 - TheStreet.com
January 2016 Options Now Available For Seattle Genetics (SGEN) 1:50 p.m. Nov. 11, 2013 - TheStreet.com
10-Q: SEATTLE GENETICS INC /WA 4:22 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog 3:50 p.m. Nov. 7, 2013 - Zacks.com
Seattle Genetics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 10:20 p.m. Nov. 5, 2013 - Seeking Alpha
Seattle Genetics, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 5, 2013 - Seeking Alpha
Immunogen's 'Smart Bomb' Cancer Drugs Are Flunking Safety Checks 9:56 a.m. Nov. 5, 2013 - TheStreet.com
The Next Great Growth Companies On Big Pharma's Radar 11:45 a.m. Nov. 4, 2013 - Seeking Alpha
CytRx Surges Ahead With Positive Drug Data 7:41 a.m. Nov. 1, 2013 - Seeking Alpha
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug 11:26 a.m. Oct. 30, 2013 - TheStreet.com
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 10:00 a.m. Today - BusinessWire
Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Dec. 4, 2013 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Nov. 26, 2013 - PR Newswire
Seattle Genetics to Present Clinical Data from Broad ADCETRIS(R) (Brentuximab Vedotin) Development Program and Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 9:00 a.m. Nov. 11, 2013 - BusinessWire
Critical Alerts For JPMorgan, ExOne, Target, NVIDIA, and Seattle Genetics Released By InvestorsObserver 9:31 a.m. Nov. 8, 2013 - PR Newswire
Marketing Authorization Applications, Financial Results, Product Up-gradations, and Presentations - Research Report on Baxter, Seattle Genetics, IDEXX, Hill-Rom, and BioCryst 8:00 a.m. Nov. 8, 2013 - PR Newswire
Seattle Genetics to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 6, 2013 - BusinessWire
Seattle Genetics Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - BusinessWire
Morning Research: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharma Inc., and Seattle Genetics Inc. 11:34 a.m. Nov. 4, 2013 - PR Newswire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 9:00 a.m. Oct. 29, 2013 - PR Newswire
Seattle Genetics Initiates Phase 1 Trial of ADC Candidate, SGN-LIV1A, for Patients with LIV-1-Positive Metastatic Breast Cancer 9:00 a.m. Oct. 21, 2013 - BusinessWire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc. 11:35 a.m. Oct. 15, 2013 - PR Newswire
Seattle Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2013 Financial Results on November 5, 2013 9:00 a.m. Oct. 15, 2013 - BusinessWire
Seattle Genetics Highlights ADCETRIS(R) (Brentuximab Vedotin) Clinical Data in the Frontline Setting at the International Symposium on Hodgkin Lymphoma 9:00 a.m. Oct. 11, 2013 - BusinessWire
Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris 8:00 a.m. Oct. 7, 2013 - PR Newswire
Critical Alerts For Exxon Mobil, Citigroup, Dollar Tree, Oracle, and Seattle Genetics Released By InvestorsObserver 9:31 a.m. Oct. 3, 2013 - PR Newswire
Prevencio, Inc. Appoints H. Perry Fell, Ph.D., as Board Chairman and Rhonda F. Rhyne as President, Chief Executive Officer, and Board Director 9:00 a.m. Oct. 2, 2013 - BusinessWire
Seattle Genetics Announces Clinical Leadership Appointments 9:00 a.m. Oct. 2, 2013 - BusinessWire
December pullback triggers first technical test 11:33 a.m. Dec. 5, 2013 - Michael Ashbaugh
Six stocks to watch for some upside 2:21 p.m. April 11, 2013 - The Trading Deck
S&P 500 takes flight, reaches record territory 9:55 a.m. April 11, 2013 - Michael Ashbaugh
Five bullish charts to watch 3:15 p.m. March 7, 2013 - The Trading Deck
Thursday’s biggest movers; Apple at 5-month low 5:27 p.m. Nov. 8, 2012 - Sue Chang
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
2012 biotech medal winners ... so far 11:01 p.m. July 31, 2012 - Gil Morales
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three technical tests converge 9:40 a.m. July 18, 2012 - Michael Ashbaugh
MoKa's Morales sees Facebook, LinkedIn on cutting edge 11:34 a.m. June 25, 2012 - blogs.marketwatch.com
Tuesday’s biggest gaining and declining stocks 5:47 p.m. Feb. 14, 2012 - Sue Chang
Rackspace Hosting, Yingli rise after hours 5:44 p.m. Feb. 13, 2012 - Myra P. Saefong
Seattle Genetics falls on growth concerns 1:42 p.m. Nov. 4, 2011 - MarketWatch.com
ECB rattles the technical backdrop 9:45 a.m. Nov. 3, 2011 - Michael Ashbaugh
U.S. markets break from the “crash” range 11:19 a.m. Oct. 24, 2011 - Michael Ashbaugh
S&P 500 rattles the cage on a trend shift 9:35 a.m. Oct. 10, 2011 - Michael Ashbaugh
3 biotech stocks battle the ‘Dendreon Effect’ 6:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 2:49 p.m. July 15, 2011 - Kate Gibson
Seattle Genetics slides 11% on drug launch worries 9:06 a.m. July 15, 2011 - Val Brickates Kennedy
SEC sues Seattle Genetics employee over trades 12:43 p.m. Jan. 21, 2011 - Steve Goldstein
Seattle Genetics presents results from study of ADC candidate in B-cell malignancies 59 min ago - Seeking Alpha
Seattle Genetics Presents Interim Phase 1 from Novel Antibody-Drug Conjugate SGN-CD19A at ASH 2013 10:03 a.m. Today - benzinga.com
Insider Trading Alert - CTL, CNQR, EXPR, DLTR And SGEN Traded By Insiders 10:31 a.m. Dec. 6, 2013 - TheStreet.com
Top Insider Trades: SGEN RST ACCL DLTR 10:02 a.m. Dec. 6, 2013 - TheStreet.com
Seattle Genetics Inc. (SGEN): Today's Featured Drugs Winner 5:02 p.m. Dec. 3, 2013 - TheStreet.com
Bayer Eyeing Norwegian Oncology Firm - Analyst Blog 5:00 p.m. Nov. 27, 2013 - Zacks.com
A Hedge Fund is Buying Shares in These 2 Biotech Stocks 2:20 p.m. Nov. 27, 2013 - Wall St. Cheat Sheet
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
Cramer's Mad Money - 11 Things To Watch In The Week Ahead (11/22/13) 6:24 a.m. Nov. 24, 2013 - Seeking Alpha
Seattle Genetics' CEO Presents at Jefferies 2013 Global Healthcare Conference (Transcript) 9:06 a.m. Nov. 20, 2013 - Seeking Alpha
Seattle Genetics Larger Than S&P 500 Component E*trade Financial 4:41 p.m. Nov. 19, 2013 - TheStreet.com
January 2016 Options Now Available For Seattle Genetics (SGEN) 1:50 p.m. Nov. 11, 2013 - TheStreet.com
10-Q: SEATTLE GENETICS INC /WA 4:22 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog 3:50 p.m. Nov. 7, 2013 - Zacks.com
Seattle Genetics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 10:20 p.m. Nov. 5, 2013 - Seeking Alpha
Seattle Genetics, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 5, 2013 - Seeking Alpha
Immunogen's 'Smart Bomb' Cancer Drugs Are Flunking Safety Checks 9:56 a.m. Nov. 5, 2013 - TheStreet.com
The Next Great Growth Companies On Big Pharma's Radar 11:45 a.m. Nov. 4, 2013 - Seeking Alpha
CytRx Surges Ahead With Positive Drug Data 7:41 a.m. Nov. 1, 2013 - Seeking Alpha
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug 11:26 a.m. Oct. 30, 2013 - TheStreet.com
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 10:00 a.m. Today - BusinessWire
Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Dec. 4, 2013 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Nov. 26, 2013 - PR Newswire
Seattle Genetics to Present Clinical Data from Broad ADCETRIS(R) (Brentuximab Vedotin) Development Program and Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 9:00 a.m. Nov. 11, 2013 - BusinessWire
Critical Alerts For JPMorgan, ExOne, Target, NVIDIA, and Seattle Genetics Released By InvestorsObserver 9:31 a.m. Nov. 8, 2013 - PR Newswire
Marketing Authorization Applications, Financial Results, Product Up-gradations, and Presentations - Research Report on Baxter, Seattle Genetics, IDEXX, Hill-Rom, and BioCryst 8:00 a.m. Nov. 8, 2013 - PR Newswire
Seattle Genetics to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 6, 2013 - BusinessWire
Seattle Genetics Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - BusinessWire
Morning Research: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharma Inc., and Seattle Genetics Inc. 11:34 a.m. Nov. 4, 2013 - PR Newswire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 9:00 a.m. Oct. 29, 2013 - PR Newswire
Seattle Genetics Initiates Phase 1 Trial of ADC Candidate, SGN-LIV1A, for Patients with LIV-1-Positive Metastatic Breast Cancer 9:00 a.m. Oct. 21, 2013 - BusinessWire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc. 11:35 a.m. Oct. 15, 2013 - PR Newswire
Seattle Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2013 Financial Results on November 5, 2013 9:00 a.m. Oct. 15, 2013 - BusinessWire
Seattle Genetics Highlights ADCETRIS(R) (Brentuximab Vedotin) Clinical Data in the Frontline Setting at the International Symposium on Hodgkin Lymphoma 9:00 a.m. Oct. 11, 2013 - BusinessWire
Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris 8:00 a.m. Oct. 7, 2013 - PR Newswire
Critical Alerts For Exxon Mobil, Citigroup, Dollar Tree, Oracle, and Seattle Genetics Released By InvestorsObserver 9:31 a.m. Oct. 3, 2013 - PR Newswire
Prevencio, Inc. Appoints H. Perry Fell, Ph.D., as Board Chairman and Rhonda F. Rhyne as President, Chief Executive Officer, and Board Director 9:00 a.m. Oct. 2, 2013 - BusinessWire
Seattle Genetics Announces Clinical Leadership Appointments 9:00 a.m. Oct. 2, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼